Education
About Us
Working with TipRanks
Follow Us
Bruker Corp (BRKR)
NASDAQ:BRKR
BRKR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$28.53 - $72.94
Previous CloseN/A
Volume340.61K
Average Volume (3M)4.23M
Market Cap
$4.87B
Enterprise Value$8.66B
Total Cash (Recent Filing)$92.00M
Total Debt (Recent Filing)$2.44B
Price to Earnings (P/E)63.5
Beta1.10
Next Earnings
Oct 30, 2025EPS Estimate
0.33Next Dividend Ex-Date
Sep 23, 2025Dividend Yield0.62%
Share Statistics
EPS (TTM)0.32
Shares Outstanding151,719,360
10 Day Avg. Volume7,026,948
30 Day Avg. Volume4,229,256
Financial Highlights & Ratios
PEG Ratio-1.04
Price to Book (P/B)4.90
Price to Sales (P/S)2.59
P/FCF Ratio64.22
Enterprise Value/Market Cap1.78
Enterprise Value/Revenue2.51
Enterprise Value/Gross Profit5.24
Enterprise Value/Ebitda21.62
Forecast
1Y Price Target
$44.89Price Target Upside39.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Bulls Say, Bears Say
Bulls Say
Cost SavingsManagement's new $100-120M run rate cost-savings initiative should drive $30M of savings in FY25 and at least 300 bps of operating margin expansion in FY26.
Debt ManagementThe capital raise lifts the overhang from the 2026-27 debt covenants, making investors more likely to get involved at currently attractive valuations despite macro headwinds.
Government FundingPotential upside is seen from China stimulus, which should become more pronounced as the year progresses.
Bears Say
Leverage PressureGross leverage breached 4x at 2Q-end, and management noted that subsequent to 2Q-end, they had borrowed an additional $457M of debt under the credit agreement, which brings calculations closer to 5x.
Market WeaknessBRKR continues to face broad-based demand pressure with no near-term relief in sight across academic, government, industrial, and biopharma sectors.
TariffsA new executive order raised Switzerland tariffs to 39%, creating a headwind given BRKR's manufacturing base.
Bruker News
BRKR FAQ
What was Bruker Corp’s price range in the past 12 months?
Bruker Corp lowest stock price was $28.53 and its highest was $72.94 in the past 12 months.
What is Bruker Corp’s market cap?
Bruker Corp’s market cap is $4.87B.
When is Bruker Corp’s upcoming earnings report date?
Bruker Corp’s upcoming earnings report date is Oct 30, 2025 which is in 41 days.
How were Bruker Corp’s earnings last quarter?
Bruker Corp released its earnings results on Aug 04, 2025. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.412 by -$0.092.
Is Bruker Corp overvalued?
According to Wall Street analysts Bruker Corp’s price is currently Undervalued.
Does Bruker Corp pay dividends?
Bruker Corp pays a Quarterly dividend of $0.05 which represents an annual dividend yield of 0.62%. See more information on Bruker Corp dividends here
What is Bruker Corp’s EPS estimate?
Bruker Corp’s EPS estimate is 0.33.
How many shares outstanding does Bruker Corp have?
Bruker Corp has 151,719,360 shares outstanding.
What happened to Bruker Corp’s price movement after its last earnings report?
Bruker Corp reported an EPS of $0.32 in its last earnings report, missing expectations of $0.412. Following the earnings report the stock price went down -8.608%.
Which hedge fund is a major shareholder of Bruker Corp?
Currently, no hedge funds are holding shares in BRKR
Bruker Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$44.89 (39.80% Upside)
$44.89 (39.80% Upside)
Blogger Sentiment
Bullish
BRKR Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 243.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $114.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 9.0%
Last 30 Days ▲ 32.4%
Last 30 Days ▲ 32.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.46%
12-Months-Change
Fundamentals
Return on Equity
4.43%
Trailing 12-Months
Asset Growth
7.41%
Trailing 12-Months
Company Description
Bruker Corp
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
BRKR Company Deck
BRKR Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted successful product innovations and a strategic cost savings initiative. However, significant revenue declines, EPS reductions, and challenges in key markets such as the U.S. and China, coupled with unfavorable tariff and currency conditions, paint a mixed picture. While the company is optimistic about future growth and margin improvements, current market conditions are challenging.View all BRKR earnings summariesBRKR Stock 12 Month Forecast
Average Price Target
$44.89
▲(39.80% Upside)
Technical Analysis
Ownership Overview
26.98% Insiders
23.94% Mutual Funds
32.64% Other Institutional Investors
0.62% Public Companies and Individual Investors